- Home
- BFST vs TLRY Comparison
BFST vs TLRY Comparison
Compare BFST & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BFST | TLRY |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 883.2M | 919.2M |
| IPO Year | 2014 | 2018 |
Fundamental Metrics
Financial Performance| Metric | BFST | TLRY |
|---|---|---|
| Price | $25.95 | $7.01 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | $32.75 | ★ $103.33 |
| AVG Volume (30 Days) | 151.0K | ★ 2.4M |
| Earning Date | 04-23-2026 | 04-08-2026 |
| Dividend Yield | ★ 2.25% | N/A |
| EPS Growth | ★ 23.45 | N/A |
| EPS | ★ 2.79 | N/A |
| Revenue | ★ $10,704,000.00 | N/A |
| Revenue This Year | $22.53 | $7.39 |
| Revenue Next Year | $4.86 | $4.76 |
| P/E Ratio | $9.54 | ★ N/A |
| Revenue Growth | ★ 1.20 | N/A |
| 52 Week Low | $20.93 | $0.36 |
| 52 Week High | $30.32 | $15.70 |
Technical Indicators
Market Signals| Indicator | BFST | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 31.76 | 38.12 |
| Support Level | $25.51 | $1.00 |
| Resistance Level | $26.10 | $8.20 |
| Average True Range (ATR) | 0.76 | 0.35 |
| MACD | -0.31 | -0.04 |
| Stochastic Oscillator | 6.42 | 13.41 |
Price Performance
Historical ComparisonAbout BFST Business First Bancshares Inc.
Business First Bancshares Inc is a bank holding company. The company's services include personal and commercial banking, treasury management, and wealth solutions. It provides a range of financial services to small-to-midsized businesses and professionals. The company generates the majority of its revenues from interest income on loans, customer service and loan fees, and interest income from securities.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.